Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

C O N M E D Cp (CNMD)

C O N M E D Cp (CNMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,409,234
  • Shares Outstanding, K 28,231
  • Annual Sales, $ 859,630 K
  • Annual Income, $ 40,850 K
  • 60-Month Beta 0.62
  • Price/Sales 2.84
  • Price/Cash Flow 19.50
  • Price/Book 3.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.53
  • Number of Estimates 4
  • High Estimate 0.54
  • Low Estimate 0.52
  • Prior Year 0.46
  • Growth Rate Est. (year over year) +15.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.48 +3.33%
on 06/18/19
88.71 -3.92%
on 07/11/19
+2.08 (+2.50%)
since 06/17/19
3-Month
76.91 +10.82%
on 04/18/19
88.71 -3.92%
on 07/11/19
+6.96 (+8.89%)
since 04/17/19
52-Week
56.90 +49.78%
on 12/26/18
88.71 -3.92%
on 07/11/19
+11.25 (+15.21%)
since 07/17/18

Most Recent Stories

More News
LH vs. CNMD: Which Stock Is the Better Value Option?

LH vs. CNMD: Which Stock Is the Better Value Option?

LH : 173.87 (-0.67%)
CNMD : 85.23 (-0.13%)
37.0% Return Seen to Date on SmarTrend Conmed Corp Call (CNMD)

SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 7 months, Conmed Corp has returned 36.98% as of today's recent price of $86.42.

CNMD : 85.23 (-0.13%)
Conmed Corp Up 37.3% Since SmarTrend Uptrend Call (CNMD)

SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 6 months, Conmed Corp has returned 37.30% as of today's recent price of $86.62.

CNMD : 85.23 (-0.13%)
Here's Why You Should Invest in CONMED (CNMD) Stock Now

CONMED (CNMD) continues to benefit from robust international sales, broad product portfolio and persistent focus on R&D.

OXFD : 12.91 (-1.97%)
BIO : 308.53 (-0.28%)
HAE : 122.00 (-0.47%)
CNMD : 85.23 (-0.13%)
Myriad Genetics' Elevate 2020 Plan Holds Promise Amid Issues

Myriad Genetics (MYGN) unveils an 'Elevate 2020' program that aims to generate $50 million in incremental operating income by fiscal 2020.

MYGN : 26.30 (+1.19%)
PEN : 174.05 (+2.57%)
XRAY : 56.93 (+0.81%)
CNMD : 85.23 (-0.13%)
Medtronic's Titan Spine Buyout to Boost Spine Surgery Range

Medtronic's (MDT) comprehensive biologics portfolio clubbed with Titan Spine's surface-enhanced titanium implants can enhance patient outcomes in spinal procedures.

PEN : 174.05 (+2.57%)
XRAY : 56.93 (+0.81%)
MDT : 100.92 (+1.05%)
CNMD : 85.23 (-0.13%)
Walgreens Gains on Strategic Deals, Margin Pressure Remains

Walgreens Boots' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also benefiting from a strong retail prescription market.

WBA : 54.52 (-2.31%)
PEN : 174.05 (+2.57%)
XRAY : 56.93 (+0.81%)
CNMD : 85.23 (-0.13%)
Thermo Fisher's Unit Sale May Not Ail Specialty Diagnostics

The Anatomical Pathology business of Thermo Fisher (TMO) belongs to its Specialty Diagnostics segment that serves customers across healthcare and clinical laboratories.

TMO : 287.00 (+0.28%)
PEN : 174.05 (+2.57%)
XRAY : 56.93 (+0.81%)
CNMD : 85.23 (-0.13%)
Here's Why You Should Hold Varian Medical (VAR) Stock Now

Varian (VAR) expects the Cancer Treatment Services International buyout to prove accretive to earnings per share during fiscal 2021.

VAR : 134.85 (-0.04%)
PEN : 174.05 (+2.57%)
XRAY : 56.93 (+0.81%)
CNMD : 85.23 (-0.13%)
Conmed Corp Up 37.2% Since SmarTrend Uptrend Call (CNMD)

SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 6 months, Conmed Corp has returned 37.22% as of today's recent price of $86.57.

CNMD : 85.23 (-0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade CNMD with:

Business Summary

CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology....

See More

Key Turning Points

2nd Resistance Point 86.39
1st Resistance Point 85.81
Last Price 85.23
1st Support Level 84.58
2nd Support Level 83.94

See More

52-Week High 88.71
Last Price 85.23
Fibonacci 61.8% 76.56
Fibonacci 50% 72.81
Fibonacci 38.2% 69.05
52-Week Low 56.90

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar